← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Glycan Therapeutics Corporation
Raleigh, NC
$25,429,494
Total funding
18
Grants
Funding over time
peak $4.8M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,429,494 · 18
By mechanism
R44$19,161,878 · 7
R42$1,933,798 · 1
N44$1,646,541 · 1
R43$1,212,773 · 4
R41$1,175,057 · 4
N43$299,447 · 1
Investigators at Glycan Therapeutics Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
Development of heparan sulfate-based therapeutics to treat inflammatory diseases$1,463,275
R44 · FY2024 · GM
Developing Heparan Sulfate Glycan Array$1,443,680
R44 · FY2020 · GM
Development of a New Carbohydrate-based Anticoagulant Drug$1,248,861
R44 · FY2020 · HL
Development of a New Carbohydrate-based Anticoagulant Drug$1,244,412
R44 · FY2019 · HL
Diverse Heparan Sulfate Oligosaccharide Libraries For Understanding and Therapeutically Manipulating Glycosaminoglycans$1,229,662
R44 · FY2020 · GM
Diverse Heparan Sulfate Oligosaccharide Libraries For Understanding and Therapeutically Manipulating Glycosaminoglycans$1,200,327
R44 · FY2021 · GM
Development of anticoagulant sulfated glycans$1,090,303
R44 · FY2024 · GM
Synthesis of the library of heparan sulfate hexasaccharide mimetics$1,075,790
R44 · FY2025 · GM
Synthesis of the library of heparan sulfate hexasaccharide mimetics$1,075,154
R44 · FY2024 · GM
Development of anticoagulant sulfated glycans$1,061,433
R44 · FY2025 · GM
Development of dekaparin to replace animal-sourced heparin$991,212
R44 · FY2025 · HL
Development of analytical methods for glycosaminoglycans from biological sources$988,771
R44 · FY2022 · GM
Development of analytical methods for glycosaminoglycans from biological sources$988,771
R44 · FY2023 · GM
Developing Heparan Sulfate Glycan Array$968,047
R44 · FY2021 · GM
IGF::OT::IGF CHEMOENZYMATIC SYNTHESIS OF HEPARAN SULFATE OLIGOSACCHARIDES$952,831
N44 · FY2015 · CA
Development of heparan sulfate-based therapeutics to treat inflammatory diseases$874,308
R44 · FY2023 · GM
Development of dekaparin to replace animal-sourced heparin$747,280
R44 · FY2024 · HL
Enzymatic synthesis of heparin sulfate and chondroitin sulfate$743,671
R42 · FY2019 · GM
Enzymatic synthesis of heparin sulfate and chondroitin sulfate$736,388
R42 · FY2020 · GM
IGF::OT::IGF CHEMOENZYMATIC SYNTHESIS OF HEPARAN SULFATE OLIGOSACCHARIDES$693,710
N44 · FY2017 · CA